TREPROSTINIL Pharmacologic Class Indexing
- Class set ID
- c1ff57ca-e482-4ddf-9951-44a03e7fb94d
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use TYVASO safely and effectively. See full prescribing information for TYVASO. TYVASO ® (treprostinil) inhalation solution, for oral inhalation use Initial U.S. Approval: 2002 | United Therapeutics Corporation | 20260414 | 32 |
| These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 2002 | United Therapeutics Corporation | 20251120 | 14 |
| These highlights do not include all the information needed to use YUTREPIA™ safely and effectively. See full prescribing information for YUTREPIA™ . YUTREPIA™ (treprostinil) inhalation powder, for oral inhalation Initial U.S. Approval: 2002 | Liquidia Technologies, Inc. | 20250908 | 3 |
| These highlights do not include all the information needed to use REMODULIN safely and effectively. See full prescribing information for REMODULIN. REMODULIN ® (treprostinil) Injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002 | United Therapeutics Corporation | 20250718 | 33 |
| These highlights do not include all the information needed to use TREPROSTINIL INJECTION safely and effectively. See full prescribing information for TREPROSTINIL INJECTION. TREPROSTINIL injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002 | Alembic Pharmaceuticals Inc. | Corden Pharma S.p.A. | 20250213 | 8 |
| These highlights do not include all the information needed to use ORENITRAM safely and effectively. See Full Prescribing Information for ORENITRAM. ORENITRAM ® (treprostinil) extended-release tablets, for oral use Initial U.S. Approval: 2002 | United Therapeutics Corporation | 20241120 | 24 |
| These highlights do not include all the information needed to use TREPROSTINIL INJECTION safely and effectively. See full prescribing information for TREPROSTINIL INJECTION. TREPROSTINIL Injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002 | Sandoz Inc | 20230406 | 25 |
| These highlights do not include all the information needed to use TREPROSTINIL INJECTION safely and effectively. See full prescribing information for TREPROSTINIL INJECTION. TREPROSTINIL Injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002 | Teva Parenteral Medicines, Inc. | 20220501 | 5 |
| These highlights do not include all the information needed to use TREPROSTINIL INJECTION safely and effectively. See full prescribing information for TREPROSTINIL INJECTION. TREPROSTINIL injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002 | Dr.Reddy's Laboratories Inc., | Dr.Reddys Laboratories Limited-FTO 9 | 20211223 | 8 |